IBC's 2nd Protein Kinases
Last Modified: April 28, 2002
Conference Dates: September 9-10, 2002
Conference Location: Seaport Hotel, Boston, Massachusetts, USA
Sponsoring Group: IBC Life Sciences
Conference Web Page URL: www.LifeSciencesInfo.com/kinases/?source=2722-5 Topics Covered:
Defining Kinase Selectivity as a Predictor in Clinical Development
New Lead Discovery for Kinase Inhibitors
Kinase Target Discovery and Validation
Identifying New Kinase Inhibitor Templates
Kinases in Oncology and Non-Oncology
Indications Developing Technologies to Evaluate Selectivity/Toxicity of Kinase Inhibitors
Developing Specific Kinase Inhibitors: Role of Cellular Assay
Registration Information: Available online
Continuing Education: No
Hedgehog Pathway Key in Tamoxifen-Resistant Breast CA
Nov 7, 2012 - Noncanonical Hedgehog signaling is activated in tamoxifen-resistant tumors, and the phosphoinositide 3-kinase inhibitor/protein kinase B pathway plays a key role protecting Hedgehog signaling molecules, according to a study published in the Oct. 1 issue of Cancer Research.
Frequently Asked Questions
I Wish You Knew
How cancer patients have changed my life
Blogs and Web Chats
OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!